Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mend-Amar Ravzanaaadii"'
Autor:
Satomi Asai, Akira Seki, Yasumasa Akai, Hiromitsu Tazawa, Hidehumi Kakizoe, Mend-Amar Ravzanaaadii, Hayato Miyachi
Publikováno v:
International Journal of Infectious Diseases, Vol 115, Iss , Pp 86-92 (2022)
Objectives: We conducted a nationwide external quality assessment (EQA) study of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid amplification testing in Japan. Methods: A total of 563 public health and private sector labora
Externí odkaz:
https://doaj.org/article/29fda4ac992e4d9598e60fd54151c53c
Autor:
Ryosuke Watanabe, Satomi Asai, Hidehumi Kakizoe, Hirofumi Saeki, Atsuko Masukawa, Miki Miyazawa, Kazumi Ohtagawa, Mend-Amar Ravzanaaadii, Mika Doi, Haruyo Atsumi, Kazuo Umezawa, Hayato Miyachi
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0248397 (2021)
In the ongoing coronavirus disease 2019 (COVID-19) pandemic, PCR has been widely used for screening patients displaying relevant symptoms. The rapid detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enables prompt diagnosis an
Externí odkaz:
https://doaj.org/article/254e459f4a194327b52f00b1a15db49f
Autor:
Mend-Amar Ravzanaaadii, Yasumasa Akai, Satomi Asai, Akira Seki, Hiromitsu Tazawa, Hayato Miyachi, Hidehumi Kakizoe
Publikováno v:
International Journal of Infectious Diseases
International Journal of Infectious Diseases, Vol 115, Iss, Pp 86-92 (2022)
International Journal of Infectious Diseases, Vol 115, Iss, Pp 86-92 (2022)
Objectives We conducted a nationwide external quality assessment (EQA) study of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid amplification testing in Japan. Methods A total of 563 public health and private sector laborato
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae03b622fb802247697dbe7edff85e03
https://doi.org/10.1016/j.ijid.2021.11.022
https://doi.org/10.1016/j.ijid.2021.11.022
Autor:
Hidehumi Kakizoe, Haruyo Atsumi, Kazumi Ohtagawa, Ryosuke Watanabe, Satomi Asai, Mend-Amar Ravzanaaadii, Kazuo Umezawa, Mika Doi, Hayato Miyachi, Miki Miyazawa, Atsuko Masukawa, Hirofumi Saeki
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0248397 (2021)
PLoS ONE
PLoS ONE
In the ongoing coronavirus disease 2019 (COVID-19) pandemic, PCR has been widely used for screening patients displaying relevant symptoms. The rapid detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enables prompt diagnosis an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::175b88c8cf9a4b778e3bed5240966d0e
https://doi.org/10.1371/journal.pone.0248397
https://doi.org/10.1371/journal.pone.0248397